Clinical trial
Study of Micafungin in Patients With Invasive Candidiasis or Candidemia
NCT00105144 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00105144 |
|---|---|
| Title | Study of Micafungin in Patients With Invasive Candidiasis or Candidemia |
| Official title | A Phase 3, Randomized, Double-Blind, Comparative Study of Micafungin (FK463) Versus Caspofungin as Antifungal Treatment in Patients With Invasive Candidiasis or Candidemia |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Candidiasis, Candidemia |
| Intervention type | Drug |
| Interventions | Micafungin, Caspofungin |
| Enrollment | 611 |
| Start date | Sep 1, 2004 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Mar 8, 2005 |
| Last update posted | Sep 18, 2014 |
| Countries | Austria, Belgium, Brazil, Canada, Croatia, Czechia, France, Germany, India, Netherlands, Poland, Spain and 3 more |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: